leisure time -WSS

leisure time

author：entertainment 2025-09-06 04:17:39 - browse：81298

Beam Therapeutics said Thursday morning it would lay off 20% of its staff — or around 100 employees — and pause or reevaluate certain programs as it looks to cut costs.

It’s a notable setback for a gene-editing company that quickly raised over $1 billion in the few years after its co-founder, David Liu, described a new form of CRISPR, called base editing, that allowed researchers to change individual letters of DNA. The biotech hired rapidly, announced its intention to treat a broad range of diseases, and received clearance to start clinical trials in cancer and sickle cell.

Beam, however, has struggled to enroll patients in those trials. Meanwhile, the biotech stock market has stayed cold, including for gene-editing companies, whose technologies raise new regulatory, safety, and reimbursement questions. The pending approval of two gene therapies for sickle cell would also limit the market for Beam’s lead drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

WSS

The Affordable Care Act has saved billions in health care costs

Medicare drug price negotiation legal challenge met with skepticism

Covid vaccine financial winners and losers, from Pfizer to Novavax

Food as medicine: Medically tailored meals may get standardized

10 reasons why health care startups fail

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

leisure time

leisure time

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Activists slam private health insurers over coverage restrictions

Investment in vaccine development is lagging, report finds

Hepatitis C has a cure — but many Americans still lack access to it

Venture capital firm's plans to take over Akron hospital face hurdles

Trump demands the U.S. pay no more for drugs than other countries … again

Scientists boost immune system in aging mice by making it youthful

United colonoscopy coverage change 'may cost lives,' doctors say

Will generative AI in health care meet the fate of IBM's Dr. Watson?

hotspot

Reconstructing family trees of blood cells may help predict disease

Supreme Court mifepristone arguments center on docs' right to sue

Zyn nicotine pouches become unlikely player in latest culture war

Zyn nicotine pouches become unlikely player in latest culture war

Wegovy leads to weight loss. Can it treat depression, too?

Scientists boost immune system in aging mice by making it youthful

hotspot

entertainment

hotspot

explore